Search

Ruiwu Liu

from Sacramento, CA
Age ~55

Ruiwu Liu Phones & Addresses

  • 3239 Beretania Way, Sacramento, CA 95834 (916) 419-9758
  • 1416 Brewerton Dr, Sacramento, CA 95833
  • 1416 Brewerton Dr APT 306, Sacramento, CA 95833 (916) 924-0861

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Education

Degree: Associate degree or higher

Publications

Us Patents

Aβ-Binding Small Molecules

View page
US Patent:
8168800, May 1, 2012
Filed:
Oct 31, 2008
Appl. No.:
12/740329
Inventors:
Kit S. Lam - Davis CA, US
Ruiwu Liu - Sacramento CA, US
Hyun-Seok Hong - Davis CA, US
Izumi Maezawa - Davis CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07D 491/052
US Classification:
5483021
Abstract:
In one aspect, the present invention provides for compounds and labeled compounds of Formula I, and pharmaceutical compositions thereof. In another aspect, the present invention provides for methods of using compounds or labeled compounds of Formula I for various therapeutic and imaging purposes, including, but not limited to, treating Alzheimer's disease in patient and imaging Aβ peptide aggregates in a patient.

Heterocyclic Ligands For Integrin Imaging And Therapy

View page
US Patent:
8486370, Jul 16, 2013
Filed:
Sep 7, 2007
Appl. No.:
12/440219
Inventors:
Richard D. Carpenter - Suisun City CA, US
Mirela Andrei - Ploiesti, RO
Ruiwu Liu - Sacramento CA, US
Kit S. Lam - Davis CA, US
Mark J. Kurth - Davis CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 51/00
US Classification:
424 169
Abstract:
The present invention provides αβintegrin ligands that display high binding affinity, specificity, and stability. The ligands comprise a peptide having n independently selected amino acids, wherein at least one amino acid is an unnatural amino acid or a D-amino acid, and wherein n is an integer of from 3 to 20. Methods are provided for administering the ligands for treating cancer, inflammatory diseases, and autoimmune diseases. Also provided are methods for administering the ligands for imaging a tumor, organ, or tissue in a subject.

Alpha-4 Beta-1 Integrin Ligands For Imaging And Therapy

View page
US Patent:
20060019900, Jan 26, 2006
Filed:
May 26, 2005
Appl. No.:
11/140548
Inventors:
Kit Lam - Davis CA, US
Ruiwu Liu - Sacramento CA, US
Li Peng - Davis CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07K 7/08
C07K 7/06
C07K 5/06
A61K 38/10
A61K 38/08
US Classification:
514013000, 514014000, 514015000, 514016000, 514017000, 514018000, 530326000, 530327000, 530328000, 530329000, 530330000, 530331000
Abstract:
The present invention provides αβintegrin ligands that display high binding affinity, specificity, and stability. The ligands comprise a peptide having n independently selected amino acids, wherein at least one amino acid is an unnatural amino acid or a D-amino acid, and wherein n is an integer of from 3 to 20. Methods are provided for administering the ligands for treating cancer, inflammatory diseases, and autoimmune diseases. Also provided are methods for administering the ligands for imaging a tumor, organ, or tissue in a subject.

Chemical Antibodies For Immunotherapy And Imaging

View page
US Patent:
20100021379, Jan 28, 2010
Filed:
Jun 28, 2007
Appl. No.:
12/306244
Inventors:
Kit S. Lam - Davis CA, US
Pappanaicken R. Kumaresan - Sacramento CA, US
Amanda Enstrom - Sacramento CA, US
Ruiwu Liu - Sacramento CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 51/00
A61K 49/00
A61K 39/395
C12Q 1/02
C12N 9/96
C07K 16/00
US Classification:
424 149, 424 91, 424 96, 4241781, 435 29, 435188, 5303911, 5303913, 5303915, 5303917, 5303919
Abstract:
The present invention provides antibody conjugates comprising a targeting agent covalently attached to an antibody or fragment thereof. The antibody conjugates of the present invention are particularly useful for imaging a tumor, organ, or tissue and for treating diseases and disorders such as cancer, inflammatory diseases, autoimmune diseases, infectious diseases, and neurological disorders. Kits containing the antibody conjugates described herein find utility in a wide range of applications including, for example, in vivo imaging and immunotherapy.

Inhibitors Of Cyclin Kinase Inhibitor P21

View page
US Patent:
20110301192, Dec 8, 2011
Filed:
Sep 29, 2009
Appl. No.:
13/119152
Inventors:
Robert Weiss - Vacaville CA, US
Kit S. Lam - Davis CA, US
Ruiwu Liu - Sacramento CA, US
Assignee:
The regents of the University of California - Oakland CA
International Classification:
A61K 31/454
C07D 235/18
C07D 403/06
A61P 35/00
C07D 401/04
A61K 31/4184
A61K 31/4375
C07D 401/06
C07D 455/02
US Classification:
514306, 546199, 5483097, 5483061, 546138, 514322, 514394
Abstract:
The present invention provides compounds that inhibit cyclin kinase inhibitor p21, such as compounds of formula I. The present invention also provides compositions including compounds of Formula I and a pharmaceutically acceptable excipient. In addition, the present invention provides methods of inhibiting cyclin kinase inhibitor p21 and of treating cancer.
Ruiwu Liu from Sacramento, CA, age ~55 Get Report